Sensata Technologies Holding (ST) 10-Q 24 Oct 17 2017 Q3 Quarterly report Financial data

Document And Entity Information

Document And Entity Information - shares	9 Months Ended
	Sep. 30, 2017	Oct. 13, 2017
Document And Entity Information [Abstract]
Entity Registrant Name	Sensata Technologies Holding N.V.
Entity Central Index Key	1,477,294
Current Fiscal Year End Date	--12-31
Entity Filer Category	Large Accelerated Filer
Document Type	10-Q
Document Period End Date	Sep. 30, 2017
Document Fiscal Year Focus	2,017
Document Fiscal Period Focus	Q3
Amendment Flag	false
Entity Common Stock, Shares Outstanding		171,296,417

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Sep. 30, 2017	Dec. 31, 2016
Current assets:
Cash and cash equivalents	$ 612,972	$ 351,428
Accounts receivable, net of allowances of $12,561 and $11,811 as of September 30, 2017 and December 31, 2016, respectively	569,881	500,211
Inventories	447,486	389,844
Prepaid expenses and other current assets	100,935	100,002
Total current assets	1,731,274	1,341,485
Property, plant and equipment, net	735,924	724,046
Goodwill	3,005,464	3,005,464
Other intangible assets, net of accumulated amortization of $1,727,644 and $1,607,269 as of September 30, 2017 and December 31, 2016, respectively	958,972	1,075,431
Deferred income tax assets	26,678	20,695
Other assets	79,625	73,855
Total assets	6,537,937	6,240,976
Current liabilities:
Current portion of long-term debt, capital lease and other financing obligations	13,176	14,643
Accounts payable	324,119	299,198
Income taxes payable	27,031	23,889
Accrued expenses and other current liabilities	263,611	245,566
Total current liabilities	627,937	583,296
Deferred income tax liabilities	404,575	392,628
Pension and other post-retirement benefit obligations	36,192	34,878
Capital lease and other financing obligations, less current portion	29,990	32,369
Long-term debt, net	3,224,684	3,226,582
Other long-term liabilities	32,034	29,216
Total liabilities	4,355,412	4,298,969
Commitments and contingencies (Note 10)
Shareholders’ equity:
Ordinary shares, €0.01 nominal value per share, 400,000 shares authorized; 178,437 shares issued	2,289	2,289
Treasury shares, at cost, 7,140 and 7,557 shares as of September 30, 2017 and December 31, 2016, respectively	(290,894)	(306,505)
Additional paid-in capital	1,658,574	1,643,449
Retained earnings	862,954	636,841
Accumulated other comprehensive loss	(50,398)	(34,067)
Total shareholders’ equity	2,182,525	1,942,007
Total liabilities and shareholders’ equity	$ 6,537,937	$ 6,240,976

Condensed Consolidated Balance3

Condensed Consolidated Balance Sheets (Parenthetical) $ in Thousands	Sep. 30, 2017€ / shares	Sep. 30, 2017USD ($)shares	Dec. 31, 2016€ / shares	Dec. 31, 2016USD ($)shares
Current assets:
Accounts receivable, allowances | $		$ 12,561		$ 11,811
Accumulated amortization | $		$ 1,727,644		$ 1,607,269
Shareholders’ equity:
Ordinary shares, nominal value per share (in euros per share) | € / shares	€ 0.01		€ 0.01
Ordinary shares, shares authorized		400,000,000		400,000,000
Ordinary shares, shares issued		178,437,000		178,437,000
Treasury stock, shares		7,140,000		7,557,000

Condensed Consolidated Statemen

Condensed Consolidated Statements of Operations - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2017	Sep. 30, 2016	Sep. 30, 2017	Sep. 30, 2016
Income Statement [Abstract]
Net revenue	$ 819,054	$ 789,798	$ 2,466,199	$ 2,413,892
Operating costs and expenses:
Cost of revenue	527,432	508,944	1,601,190	1,574,763
Research and development	34,002	31,601	97,032	95,240
Selling, general and administrative	75,972	75,046	227,256	224,637
Amortization of intangible assets	40,317	50,562	121,578	151,572
Restructuring and special charges	1,329	837	18,768	3,167
Total operating costs and expenses	679,052	666,990	2,065,824	2,049,379
Profit from operations	140,002	122,808	400,375	364,513
Interest expense, net	(40,263)	(41,176)	(120,578)	(125,201)
Other, net	3,112	(726)	7,190	4,892
Income before taxes	102,851	80,906	286,987	244,204
Provision for income taxes	14,816	11,121	47,759	48,297
Net income	$ 88,035	$ 69,785	$ 239,228	$ 195,907
Basic net income per share (in dollars per share)	$ 0.51	$ 0.41	$ 1.40	$ 1.15
Diluted net income per share (in dollars per share)	$ 0.51	$ 0.41	$ 1.39	$ 1.14

Condensed Consolidated Stateme5

Condensed Consolidated Statements of Comprehensive Income - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2017	Sep. 30, 2016	Sep. 30, 2017	Sep. 30, 2016
Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest [Abstract]
Net income	$ 88,035	$ 69,785	$ 239,228	$ 195,907
Other comprehensive loss, net of tax:
Deferred loss on derivative instruments, net of reclassifications	(6,784)	(8,485)	(17,820)	(25,010)
Defined benefit and retiree healthcare plans	274	24	1,489	291
Other comprehensive loss	(6,510)	(8,461)	(16,331)	(24,719)
Comprehensive income	$ 81,525	$ 61,324	$ 222,897	$ 171,188

Condensed Consolidated Stateme6

Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2017	Sep. 30, 2016
Cash flows from operating activities:
Net income	$ 239,228	$ 195,907
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation	82,014	77,649
Amortization of deferred financing costs and original issue discounts	5,528	5,501
Gain on sale of assets	(1,180)	0
Share-based compensation	15,106	13,279
Amortization of inventory step-up to fair value	0	2,319
Amortization of intangible assets	121,578	151,572
Deferred income taxes	11,836	15,706
Unrealized loss on hedges and other non-cash items	5,844	660
Changes in operating assets and liabilities, net of effects of acquisitions:
Accounts receivable, net	(69,670)	(65,373)
Inventories	(58,476)	(20,624)
Prepaid expenses and other current assets	(19,251)	2,320
Accounts payable and accrued expenses	40,144	33,371
Income taxes payable	3,142	(6,361)
Other	(3,564)	(9,575)
Net cash provided by operating activities	372,279	396,351
Cash flows from investing activities:
Acquisition of CST, net of cash received	0	4,688
Additions to property, plant and equipment and capitalized software	(103,536)	(94,584)
Investment in equity securities	0	(50,000)
Proceeds from the sale of assets	8,862	751
Other	(3,000)	0
Net cash used in investing activities	(97,674)	(139,145)
Cash flows from financing activities:
Proceeds from exercise of stock options and issuance of ordinary shares	5,332	3,306
Payments on debt	(14,459)	(297,698)
Payments to repurchase ordinary shares	(2,817)	(4,672)
Payments of debt issuance costs	(137)	(518)
Other	(980)	0
Net cash used in financing activities	(13,061)	(299,582)
Net change in cash and cash equivalents	261,544	(42,376)
Cash and cash equivalents, beginning of period	351,428	342,263
Cash and cash equivalents, end of period	$ 612,972	$ 299,887

Business Description and Basis

Business Description and Basis of Presentation	9 Months Ended
	Sep. 30, 2017
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Business Description and Basis of Presentation	Business Description and Basis of Presentation Description of Business The accompanying unaudited condensed consolidated financial statements reflect the financial position, results of operations, comprehensive income, and cash flows of Sensata Technologies Holding N.V. ("Sensata N.V.") and its wholly-owned subsidiaries, collectively referred to as the "Company," "Sensata," "we," "our," or "us." Sensata N.V. is incorporated under the laws of the Netherlands and conducts its operations through subsidiary companies that operate business and product development centers primarily in the United States (the "U.S."), the Netherlands, Belgium, China, Germany, Japan, South Korea, and the United Kingdom (the "U.K."); and manufacturing operations primarily in China, Malaysia, Mexico, Bulgaria, France, Germany, the U.K., and the U.S. We organize our operations into two businesses, Performance Sensing and Sensing Solutions. On September 28, 2017, the board of directors of Sensata N.V. unanimously approved a plan to change our parent company’s location of incorporation from the Netherlands to the U.K. To effect this change, the shareholders of Sensata N.V. will be asked to approve a cross-border merger between Sensata N.V. and Sensata Technologies Holding plc (“Sensata U.K.”), a newly formed, public limited company incorporated under the laws of England and Wales, with Sensata U.K. being the surviving entity (the “Merger”). If approved by our shareholders, we would expect to complete the Merger during the first quarter of 2018, which would result in Sensata U.K. becoming the publicly-traded parent of the subsidiary companies that are currently controlled by Sensata N.V. Basis of Presentation The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles ("U.S. GAAP") for interim financial information and the instructions to Form 10-Q. Accordingly, these interim financial statements do not include all of the information and note disclosures required by U.S. GAAP for complete financial statements. The accompanying financial information reflects all normal recurring adjustments that are, in the opinion of management, necessary for a fair presentation of the interim period results. The results of operations for the three and nine months ended September 30, 2017 are not necessarily indicative of the results to be expected for the full year, nor were the results of operations of the comparable periods in 2016 necessarily representative of those actually experienced for the full year 2016 . These unaudited condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and notes thereto included in our Annual Report on Form 10-K for the year ended December 31, 2016 . All intercompany balances and transactions have been eliminated. All U.S. dollar and share amounts presented, except per share amounts, are stated in thousands, unless otherwise indicated. Certain reclassifications have been made to prior periods to conform to current period presentation.

New Accounting Standards

New Accounting Standards	9 Months Ended
	Sep. 30, 2017
New Accounting Pronouncements and Changes in Accounting Principles [Abstract]
New Accounting Standards	New Accounting Standards In May 2014, the Financial Accounting Standards Board (the "FASB") issued Accounting Standards Update ("ASU") No. 2014-09, Revenue from Contracts with Customers (Topic 606) , which creates one Accounting Standards Codification ("ASC") Topic (FASB ASC 606, Revenue from Contracts with Customers ) that replaces the current guidance found in FASB ASC 605, Revenue Recognition , and various other revenue accounting standards for specialized transactions and industries. FASB ASU No. 2014-09 outlines a comprehensive five-step revenue recognition model based on the principle that an entity should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. FASB ASU No. 2014-09 may be applied using either a full retrospective approach, under which all years included in the financial statements will be presented under the revised guidance, or a modified retrospective approach, under which financial statements will be prepared under the revised guidance for the year of adoption, but not for prior years. Under the latter method, entities will recognize a cumulative catch-up adjustment to the opening balance of retained earnings at the effective date for contracts that still require performance by the entity. In August 2015, the FASB issued ASU No. 2015-14, Revenue from Contracts with Customers (Topic 606): Deferral of Effective Date, which defers the effective date of FASB ASU No. 2014-09 by one year. FASB ASU No. 2014-09 is now effective for annual reporting periods beginning after December 15, 2017, including interim periods within those annual reporting periods. We have developed an implementation plan to adopt this new guidance. As part of this plan, we are currently assessing the impact of the new guidance on our financial position and results of operations. Based on our procedures performed to date, nothing has come to our attention that would indicate that the adoption of FASB ASU No. 2014-09 will have a material impact on our financial position or results of operations. However, we will continue to evaluate this assessment through the remainder of 2017. In addition, the adoption of FASB ASU No. 2014-09 requires new disclosures related to revenue recognition, which we are continuing to evaluate. We intend to adopt FASB ASU No. 2014-09 on January 1, 2018 using the modified retrospective transition method. In February 2016, the FASB issued ASU No. 2016-02, Leases (Topic 842) , which establishes new accounting and disclosure requirements for leases. FASB ASU No. 2016-02 requires lessees to classify most leases as either finance or operating leases and to initially recognize a lease liability and right-of-use asset. Entities may elect to account for certain short-term leases (with a term of 12 months or less) using a method similar to the current operating lease model. The statements of operations will include, for finance leases, separate recognition of interest on the lease liability and amortization of the right-of-use asset and for operating leases, a single lease cost, calculated so that the cost of the lease is allocated over the lease term on a straight-line basis. At December 31, 2016, we were contractually obligated to make future payments of $69.8 million under our operating lease obligations in existence as of that date, primarily related to long-term facility leases. While we are in the early stages of our implementation process for FASB ASU No. 2016-02, and have not yet determined its impact on our consolidated financial statements, these leases would potentially be required to be presented on the balance sheet in accordance with the requirements of FASB ASU No. 2016-02. FASB ASU No. 2016-02 is effective for annual reporting periods beginning after December 15, 2018, including interim periods within those annual reporting periods, with early adoption permitted. FASB ASU No. 2016-02 must be applied using a modified retrospective approach, which requires recognition and measurement of leases at the beginning of the earliest period presented, with certain practical expedients available. In August 2017, the FASB issued ASU No. 2017-12, Derivatives and Hedging (Topic 815) , which changes both the designation and measurement guidance for qualifying hedging relationships and the presentation of hedge results, in order to better align an entity’s risk management activities and financial reporting for hedging relationships. The amendments expand and refine hedge accounting for both nonfinancial and financial risk components and align the recognition and presentation of the effects of the hedging instrument and the hedged item in the financial statements. FASB ASU No. 2017-12 is effective for annual reporting periods beginning after December 15, 2018, including interim periods within those annual reporting periods, with early adoption permitted. We are still evaluating the impact that this guidance will have on our consolidated financial statements, and we have not yet determined whether we will early adopt FASB ASU No. 2017-12.

Inventories

Inventories	9 Months Ended
	Sep. 30, 2017
Inventory Disclosure [Abstract]
Inventories	Inventories The components of inventories as of September 30, 2017 and December 31, 2016 were as follows: September 30, December 31, Finished goods $ 191,165 $ 169,304 Work-in-process 91,569 74,810 Raw materials 164,752 145,730 Inventories $ 447,486 $ 389,844

Shareholders' Equity

Shareholders' Equity	9 Months Ended
	Sep. 30, 2017
Equity [Abstract]
Shareholders' Equity	Shareholders' Equity Treasury Shares Ordinary shares repurchased by us are recorded at cost, as treasury shares, and result in a reduction of shareholders' equity. We reissue treasury shares as part of our share-based compensation programs. The cost of reissued shares is determined using the first-in, first-out method. During the nine months ended September 30, 2017 , we reissued 0.5 million treasury shares, and as a result, we recognized a reduction in Retained earnings of $13.1 million . Accumulated Other Comprehensive Loss The following is a roll forward of the components of Accumulated other comprehensive loss for the nine months ended September 30, 2017 : Cash Flow Hedges Defined Benefit and Retiree Healthcare Plans Accumulated Other Comprehensive Loss Balance as of December 31, 2016 $ 23 $ (34,090 ) $ (34,067 ) Other comprehensive loss before reclassifications, net of tax (25,078 ) — (25,078 ) Amounts reclassified from accumulated other comprehensive loss, net of tax 7,258 1,489 8,747 Net current period other comprehensive (loss)/income (17,820 ) 1,489 (16,331 ) Balance as of September 30, 2017 $ (17,797 ) $ (32,601 ) $ (50,398 ) The details of the amounts reclassified from Accumulated other comprehensive loss for the three and nine months ended September 30, 2017 and 2016 are as follows: Amount of Loss/(Gain) Reclassified from Accumulated Other Comprehensive Loss Affected Line in Condensed Consolidated Statements of Operations For the three months ended For the nine months ended Component September 30, 2017 September 30, 2016 September 30, 2017 September 30, 2016 Derivative instruments designated and qualifying as cash flow hedges Foreign currency forward contracts $ 4,075 $ (2,771 ) $ (3,678 ) $ (15,075 ) Net revenue (1) Foreign currency forward contracts 1,953 4,834 13,356 14,857 Cost of revenue (1) Total, before taxes 6,028 2,063 9,678 (218 ) Income before taxes Income tax effect (1,507 ) (514 ) (2,420 ) 55 Provision for income taxes Total, net of taxes $ 4,521 $ 1,549 $ 7,258 $ (163 ) Net income Defined benefit and retiree healthcare plans $ 297 $ (5 ) $ 1,557 $ 324 Various (2) Income tax effect (23 ) 29 (68 ) (33 ) Provision for income taxes Total, net of taxes $ 274 $ 24 $ 1,489 $ 291 Net income (1) See Note 12, "Derivative Instruments and Hedging Activities," for additional details on amounts to be reclassified in the future from Accumulated other comprehensive loss. (2) Amounts related to defined benefit and retiree healthcare plans reclassified from Accumulated other comprehensive loss affect the Cost of revenue, Research and development, and Selling, general and administrative ("SG&A") expense line items in the condensed consolidated statements of operations. The amounts reclassified are included in the computation of net periodic benefit cost. See Note 8, "Pension and Other Post-Retirement Benefits," for additional details of net periodic benefit cost.

Restructuring and Special Charg

Restructuring and Special Charges	9 Months Ended
	Sep. 30, 2017
Restructuring and Related Activities [Abstract]
Restructuring and Special Charges	Restructuring and Special Charges Restructuring and special charges for the three and nine months ended September 30, 2017 were $1.3 million and $18.8 million , respectively, which related primarily to the closing of our facility in Minden, Germany that was part of the acquisition of certain subsidiaries of Custom Sensors & Technologies Ltd. ("CST"), facility exit costs related to a limited number of other line moves and exit activities, and severance costs related to the termination of a limited number of employees. Charges related to the closing of our facility in Minden, Germany for the three and nine months ended September 30, 2017 consisted of (i) severance charges of $0.0 million and $8.4 million , respectively, and (ii) facility exit costs of $1.3 million and $2.4 million , respectively. Restructuring and special charges for the three and nine months ended September 30, 2016 were $0.8 million and $3.2 million , respectively, which consisted primarily of facility exit costs related to the relocation of manufacturing lines from our facility in the Dominican Republic to a manufacturing facility in Mexico, and severance charges recorded in connection with acquired businesses and the termination of a limited number of employees. We completed the cessation of manufacturing in our Dominican Republic facility in the third quarter of 2016. Changes to the severance portion of our restructuring liability during the nine months ended September 30, 2017 were as follows: Severance Balance at December 31, 2016 $ 17,350 Charges, net of reversals 11,747 Payments (20,072 ) Impact of changes in foreign currency exchange rates 1,529 Balance at September 30, 2017 $ 10,554

Debt

Debt	9 Months Ended
	Sep. 30, 2017
Debt Disclosure [Abstract]
Debt	Debt Our long-term debt and capital lease and other financing obligations as of September 30, 2017 and December 31, 2016 consisted of the following: Maturity Date September 30, December 31, Term Loan October 14, 2021 $ 927,794 $ 937,794 4.875% Senior Notes October 15, 2023 500,000 500,000 5.625% Senior Notes November 1, 2024 400,000 400,000 5.0% Senior Notes October 1, 2025 700,000 700,000 6.25% Senior Notes February 15, 2026 750,000 750,000 Less: discount (15,812 ) (17,655 ) Less: deferred financing costs (29,971 ) (33,656 ) Less: current portion (7,327 ) (9,901 ) Long-term debt, net $ 3,224,684 $ 3,226,582 Capital lease and other financing obligations $ 35,839 $ 37,111 Less: current portion (5,849 ) (4,742 ) Capital lease and other financing obligations, less current portion $ 29,990 $ 32,369 As of September 30, 2017 , there was $415.3 million of availability under our $420.0 million revolving credit facility, net of $4.7 million in letters of credit. Outstanding letters of credit are issued primarily for the benefit of certain operating activities. As of September 30, 2017 , no amounts had been drawn against these outstanding letters of credit, which are scheduled to expire on various dates in 2017 and 2018. Accrued Interest Accrued interest associated with our outstanding debt is included as a component of Accrued expenses and other current liabilities in the condensed consolidated balance sheets. As of September 30, 2017 and December 31, 2016 , accrued interest totaled $45.7 million and $36.8 million , respectively.

Income Taxes

Income Taxes	9 Months Ended
	Sep. 30, 2017
Income Tax Disclosure [Abstract]
Income Taxes	Income Taxes We recorded a Provision for income taxes for the three months ended September 30, 2017 and 2016 of $14.8 million and $11.1 million , respectively, and for the nine months ended September 30, 2017 and 2016 of $47.8 million and $48.3 million , respectively. The Provision for income taxes consists of current tax expense, which relates primarily to our profitable operations in non-U.S. tax jurisdictions, and deferred tax expense, which relates to adjustments in book-to-tax basis differences primarily due to the step-up in fair value of fixed and intangible assets, including goodwill, acquired in connection with business combination transactions, and the utilization of net operating losses. During the three and nine months ended September 30, 2016, we recognized a benefit from income taxes of $5.1 million and $3.7 million , respectively, related to the change in our U.S. valuation allowance associated with the acquisition of CST, for which deferred tax liabilities were established related primarily to the step-up of tangible assets for book purposes.

Pension and Other Post-Retireme

Pension and Other Post-Retirement Benefits	9 Months Ended
	Sep. 30, 2017
Retirement Benefits [Abstract]
Pension and Other Post-Retirement Benefits	Pension and Other Post-Retirement Benefits We provide various pension and other post-retirement benefit plans for current and former employees, including defined benefit, defined contribution, and retiree healthcare benefit plans. The components of net periodic benefit cost/(credit) associated with our defined benefit and retiree healthcare plans for the three months ended September 30, 2017 and 2016 were as follows: U.S. Plans Non-U.S. Plans Defined Benefit Retiree Healthcare Defined Benefit Total September 30, September 30, September 30, September 30, 2017 2016 2017 2016 2017 2016 2017 2016 Service cost $ — $ — $ 21 $ 25 $ 661 $ 697 $ 682 $ 722 Interest cost 385 332 80 94 273 298 738 724 Expected return on plan assets (527 ) (659 ) — — (230 ) (249 ) (757 ) (908 ) Amortization of net loss 291 118 8 46 64 42 363 206 Amortization of prior service (credit) — — (334 ) (334 ) (1 ) (18 ) (335 ) (352 ) Loss on settlement 269 140 — — — 1 269 141 Net periodic benefit cost/(credit) $ 418 $ (69 ) $ (225 ) $ (169 ) $ 767 $ 771 $ 960 $ 533 The components of net periodic benefit cost/(credit) associated with our defined benefit and retiree healthcare plans for the nine months ended September 30, 2017 and 2016 were as follows: U.S. Plans Non-U.S. Plans Defined Benefit Retiree Healthcare Defined Benefit Total September 30, September 30, September 30, September 30, 2017 2016 2017 2016 2017 2016 2017 2016 Service cost $ — $ — $ 64 $ 76 $ 1,917 $ 2,003 $ 1,981 $ 2,079 Interest cost 1,214 1,109 239 283 784 887 2,237 2,279 Expected return on plan assets (1,617 ) (2,006 ) — — (677 ) (714 ) (2,294 ) (2,720 ) Amortization of net loss 854 355 32 142 202 89 1,088 586 Amortization of prior service (credit)/cost — — (1,001 ) (1,001 ) (3 ) 8 (1,004 ) (993 ) Loss on settlement 1,473 730 — — — 1 1,473 731 Net periodic benefit cost/(credit) $ 1,924 $ 188 $ (666 ) $ (500 ) $ 2,223 $ 2,274 $ 3,481 $ 1,962

Share-Based Payment Plans

Share-Based Payment Plans	9 Months Ended
	Sep. 30, 2017
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
Share-Based Payment Plans	Share-Based Payment Plans Share-Based Compensation Expense The table below presents non-cash compensation expense related to our equity awards, which is recorded within SG&A expense in the condensed consolidated statements of operations, during the identified periods: For the three months ended For the nine months ended September 30, 2017 September 30, 2016 September 30, 2017 September 30, 2016 Stock options $ 1,575 $ 1,621 $ 5,055 $ 5,547 Restricted securities 3,522 3,136 10,051 7,732 Share-based compensation expense $ 5,097 $ 4,757 $ 15,106 $ 13,279 Share-Based Compensation Awards We grant share-based compensation awards for which vesting is subject only to continued employment and the passage of time (options and restricted stock units ("RSUs" and each an "RSU")), as well as those for which vesting also depends on the attainment of certain performance criteria (performance-based options and performance-based restricted stock units ("PRSUs" and each a "PRSU")). We granted the following options under the Sensata Technologies Holding N.V. 2010 Equity Incentive Plan (the "2010 Equity Plan") during the nine months ended September 30, 2017 : Options Granted to Number of Options Granted (in thousands) Weighted- Average Grant Date Fair Value Vesting Period Various executives and employees 387 $14.50 25% per year over four years We granted the following RSUs and PRSUs under the 2010 Equity Plan during the nine months ended September 30, 2017 : Awards Granted to Type of Award Number of Units Granted (in thousands) Percentage of PRSUs Awarded That May Vest Weighted- Average Grant Date Fair Value Various executives and employees RSU (1) 147 N/A $43.67 Directors RSU (1) 34 N/A $41.10 Various executives and employees PRSU (2) 183 0.0% - 172.5% $43.67 Various executives and employees PRSU (2) 53 0.0% - 200.0% $43.33 (1) RSUs granted during the nine months ended September 30, 2017 vest on various dates between June 2018 and July 2020. (2) PRSUs granted during the nine months ended September 30, 2017 vest on various dates between April and May 2020, with the amount ultimately vesting within the range shown in the table above, dependent on the extent to which certain performance criteria are met. Option Exercises During the nine months ended September 30, 2017 , 266 stock options were exercised, all of which were settled with shares reissued from treasury.

Commitments and Contingencies

Commitments and Contingencies	9 Months Ended
	Sep. 30, 2017
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	Commitments and Contingencies Legal Proceedings and Claims We are regularly involved in a number of claims and litigation matters in the ordinary course of business. Most of our litigation matters are third-party claims for property damage allegedly caused by our products but some involve allegations of personal injury or wrongful death. Although it is not feasible to predict the outcome of these matters, based upon our experience and current information known to us, we do not expect the outcome of these matters, either individually or in the aggregate, to have a material adverse effect on our result of operations, financial position, or cash flows.

Fair Value Measures

Fair Value Measures	9 Months Ended
	Sep. 30, 2017
Fair Value Disclosures [Abstract]
Fair Value Measures	Fair Value Measures Our assets and liabilities recorded at fair value have been categorized based upon a fair value hierarchy in accordance with FASB ASC 820, Fair Value Measurement . Measured on a Recurring Basis The following table presents information about our assets and liabilities measured at fair value on a recurring basis as of September 30, 2017 and December 31, 2016 , aggregated by the level in the fair value hierarchy within which those measurements fell: September 30, 2017 December 31, 2016 Quoted Prices in Active Markets for Identical Assets (Level 1) Significant Other Observable Inputs (Level 2) Significant Unobservable Inputs (Level 3) Quoted Prices in Active Markets for Identical Assets (Level 1) Significant Other Observable Inputs (Level 2) Significant Unobservable Inputs (Level 3) Assets Foreign currency forward contracts $ — $ 8,869 $ — $ — $ 32,757 $ — Commodity forward contracts — 4,847 — — 2,639 — Total $ — $ 13,716 $ — $ — $ 35,396 $ — Liabilities Foreign currency forward contracts $ — $ 31,911 $ — $ — $ 27,201 $ — Commodity forward contracts — 1,666 — — 3,790 — Total $ — $ 33,577 $ — $ — $ 30,991 $ — Measured on a Nonrecurring Basis We evaluated our goodwill and other indefinite-lived intangible assets for impairment as of October 1, 2016 and determined that these assets were not impaired. As of September 30, 2017 , no events or changes in circumstances occurred that would have triggered the need for an additional impairment review of goodwill or indefinite-lived intangible assets. A long-lived asset, which includes Property, plant, and equipment ("PP&E"), is considered held for sale when it meets certain criteria described in FASB ASC 360, Property, Plant, and Equipment . A long-lived asset classified as held for sale is initially measured at the lower of its carrying amount or fair value less cost to sell, and a loss is recognized for any initial adjustment of the asset's carrying amount to its fair value less cost to sell in the period the held for sale criteria are met. In the period that a long-lived asset is considered held for sale it is presented within Prepaid expenses and other current assets on our balance sheet where it remains until it is either sold or no longer meets the held for sale criteria. For comparative purposes, the prior year carrying amount of a long-lived asset considered held for sale is presented within Other assets on our balance sheet. In the first quarter of 2017, we determined that one of our facilities met the held for sale criteria and recorded it at its fair value less costs to sell of $1.7 million (which approximated its net carrying value at that time). In the third quarter of 2017, we sold the asset for an immaterial gain. The fair value of assets held for sale is considered to be a Level 3 fair value measurement and is determined based on the use of appraisals, input from market participants, our experience selling similar assets, internally developed cash flow models, or a combination thereof. Financial Instruments Not Recorded at Fair Value The following table presents the carrying values and fair values of financial instruments not recorded at fair value in the condensed consolidated balance sheets as of September 30, 2017 and December 31, 2016 : September 30, 2017 December 31, 2016 Carrying Value (1) Fair Value Carrying Value (1) Fair Value Level 1 Level 2 Level 3 Level 1 Level 2 Level 3 Liabilities Term Loan $ 927,794 $ — $ 932,433 $ — $ 937,794 $ — $ 942,483 $ — 4.875% Senior Notes $ 500,000 $ — $ 525,000 $ — $ 500,000 $ — $ 514,375 $ — 5.625% Senior Notes $ 400,000 $ — $ 440,000 $ — $ 400,000 $ — $ 417,752 $ — 5.0% Senior Notes $ 700,000 $ — $ 736,750 $ — $ 700,000 $ — $ 686,000 $ — 6.25% Senior Notes $ 750,000 $ — $ 819,375 $ — $ 750,000 $ — $ 786,098 $ — (1) Carrying value excludes discounts and deferred financing costs. The fair values of the Term Loan and senior notes are primarily determined using observable prices in markets where these instruments are generally not traded on a daily basis. Cash and cash equivalents, accounts receivable, and accounts payable are carried at their cost, which approximates fair value, because of their short-term nature. In March 2016, we acquired $50.0 million of Series B Preferred Stock of Quanergy Systems, Inc., which we recognized as a cost method investment on our balance sheet. As of September 30, 2017 , the fair value of this asset has not been estimated, as there are no indicators of impairment, and it is not practicable to estimate its fair value due to the restricted marketability of this investment.

Derivative Instruments and Hedg

Derivative Instruments and Hedging Activities	9 Months Ended
	Sep. 30, 2017
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Derivative Instruments and Hedging Activities	Derivative Instruments and Hedging Activities Hedges of Foreign Currency Risk We are exposed to fluctuations in various foreign currencies against our functional currency, the U.S. dollar. We use foreign currency forward agreements to manage this exposure. We currently have outstanding foreign currency forward contracts that qualify as cash flow hedges intended to offset the effect of exchange rate fluctuations on forecasted sales and certain manufacturing costs. We also have outstanding foreign currency forward contracts that are intended to preserve the economic value of foreign currency denominated monetary assets and liabilities; these instruments are not designated for hedge accounting treatment in accordance with FASB ASC 815, Derivatives and Hedging . Foreign currency forward contracts not designated as hedges are not speculative and are used to manage our exposure to foreign exchange movements. For the three and nine months ended September 30, 2017 and 2016, the ineffective portion of the changes in the fair value of our foreign currency forward agreements that are designated as cash flow hedges was not material and no amounts were excluded from the assessment of effectiveness. As of September 30, 2017 , we estimate that $18.4 million of net losses will be reclassified from Accumulated other comprehensive loss to earnings during the twelve-month period ending September 30, 2018 . As of September 30, 2017 , we had the following outstanding foreign currency forward contracts: Notional (in millions) Effective Date(s) Maturity Date(s) Index Weighted- Average Strike Rate Hedge Designation 65.0 EUR September 27, 2017 October 31, 2017 Euro to U.S. Dollar Exchange Rate 1.18 USD Not designated 461.6 EUR Various from April 2015 to September 2017 Various from October 2017 to December 2019 Euro to U.S. Dollar Exchange Rate 1.14 USD Designated 500.0 CNY September 26, 2017 October 31, 2017 U.S. Dollar to Chinese Renminbi Exchange Rate 6.68 CNY Not designated 132.0 CNY Various in February 2017 Various from October to December 2017 U.S. Dollar to Chinese Renminbi Exchange Rate 7.05 CNY Designated 110.0 JPY September 27, 2017 October 31, 2017 U.S. Dollar to Japanese Yen Exchange Rate 112.80 JPY Not designated 237.0 JPY January 5, 2017 Various from October to December 2017 U.S. Dollar to Japanese Yen Exchange Rate 113.71 JPY Designated 45,258.3 KRW Various from April 2015 to September 2017 Various from October 2017 to August 2019 U.S. Dollar to Korean Won Exchange Rate 1,140.77 KRW Designated 36.5 MYR Various from April 2015 to November 2016 Various from October 2017 to October 2018 U.S. Dollar to Malaysian Ringgit Exchange Rate 4.19 MYR Designated 182.0 MXN September 27, 2017 October 31, 2017 U.S. Dollar to Mexican Peso Exchange Rate 18.24 MXN Not designated 2,166.8 MXN Various from April 2015 to September 2017 Various from October 2017 to August 2019 U.S. Dollar to Mexican Peso Exchange Rate 19.94 MXN Designated 44.5 GBP Various from April 2015 to September 2017 Various from October 2017 to August 2019 British Pound Sterling to U.S. Dollar Exchange Rate 1.33 USD Designated The notional amounts above represent the total quantities we have outstanding over the remaining contracted periods. Hedges of Commodity Risk Our objective in using commodity forward contracts is to offset a portion of our exposure to the potential change in prices associated with certain commodities used in the manufacturing of our products, including silver, gold, nickel, aluminum, copper, platinum, and palladium. The terms of these forward contracts fix the price at a future date for various notional amounts associated with these commodities. These instruments are not designated for hedge accounting treatment in accordance with FASB ASC 815. Commodity forward contracts not designated as hedges are not speculative and are used to manage our exposure to commodity price movements. We had the following outstanding commodity forward contracts, none of which were designated as derivatives in qualifying hedging relationships, as of September 30, 2017 : Commodity Notional Remaining Contracted Periods Weighted-Average Strike Price Per Unit Silver 1,109,455 troy oz. October 2017 - August 2019 $17.69 Gold 12,150 troy oz. October 2017 - August 2019 $1,269.40 Nickel 287,659 pounds October 2017 - August 2019 $4.68 Aluminum 5,554,370 pounds October 2017 - August 2019 $0.84 Copper 7,394,018 pounds October 2017 - August 2019 $2.54 Platinum 8,036 troy oz. October 2017 - August 2019 $996.80 Palladium 1,927 troy oz. October 2017 - August 2019 $759.11 The notional amounts above represent the total quantities we have outstanding over the remaining contracted periods. Financial Instrument Presentation The following table presents the fair values of our derivative financial instruments and their classification in the condensed consolidated balance sheets as of September 30, 2017 and December 31, 2016 : Asset Derivatives Liability Derivatives Fair Value Fair Value Balance Sheet Location September 30, 2017 December 31, 2016 Balance Sheet Location September 30, 2017 December 31, 2016 Derivatives designated as hedging instruments Foreign currency forward contracts Prepaid expenses and other current assets $ 6,909 $ 24,796 Accrued expenses and other current liabilities $ 23,838 $ 20,990 Foreign currency forward contracts Other assets 1,956 5,693 Other long-term liabilities 7,327 3,814 Total $ 8,865 $ 30,489 $ 31,165 $ 24,804 Derivatives not designated as hedging instruments Commodity forward contracts Prepaid expenses and other current assets $ 4,173 $ 2,097 Accrued expenses and other current liabilities $ 1,400 $ 2,764 Commodity forward contracts Other assets 674 542 Other long-term liabilities 266 1,026 Foreign currency forward contracts Prepaid expenses and other current assets 4 2,268 Accrued expenses and other current liabilities 746 2,397 Total $ 4,851 $ 4,907 $ 2,412 $ 6,187 These fair value measurements are all categorized within Level 2 of the fair value hierarchy. The following tables present the effect of our derivative financial instruments on the condensed consolidated statements of operations for the three months ended September 30, 2017 and 2016: Derivatives designated as hedging instruments Amount of Deferred (Loss)/Gain Recognized in Other Comprehensive Loss Location of Net (Loss)/Gain Reclassified from Accumulated Other Comprehensive Loss into Net Income Amount of Net (Loss)/Gain Reclassified from Accumulated Other Comprehensive Loss into Net Income September 30, 2017 September 30, 2016 September 30, 2017 September 30, 2016 Foreign currency forward contracts $ (16,688 ) $ (6,929 ) Net revenue $ (4,075 ) $ 2,771 Foreign currency forward contracts $ 1,614 $ (6,450 ) Cost of revenue $ (1,953 ) $ (4,834 ) Derivatives not designated as hedging instruments Amount of Gain/(Loss) Recognized in Net Income Location of Gain/(Loss) Recognized in Net Income September 30, 2017 September 30, 2016 Commodity forward contracts $ 2,956 $ 1,318 Other, net Foreign currency forward contracts $ (3,865 ) $ (3,827 ) Other, net The following tables present the effect of our derivative financial instruments on the condensed consolidated statements of operations for the nine months ended September 30, 2017 and 2016: Derivatives designated as hedging instruments Amount of Deferred (Loss)/Gain Recognized in Other Comprehensive Loss Location of Net Gain/(Loss) Reclassified from Accumulated Other Comprehensive Loss into Net Income Amount of Net Gain/(Loss) Reclassified from Accumulated Other Comprehensive Loss into Net Income September 30, 2017 September 30, 2016 September 30, 2017 September 30, 2016 Foreign currency forward contracts $ (56,479 ) $ (12,810 ) Net revenue $ 3,678 $ 15,075 Foreign currency forward contracts $ 23,041 $ (20,319 ) Cost of revenue $ (13,356 ) $ (14,857 ) Derivatives not designated as hedging instruments Amount of Gain/(Loss) Recognized in Net Income Location of Gain/(Loss) Recognized in Net Income September 30, 2017 September 30, 2016 Commodity forward contracts $ 6,439 $ 12,049 Other, net Foreign currency forward contracts $ (10,542 ) $ (7,912 ) Other, net Credit Risk Related Contingent Features We have agreements with certain of our derivative counterparties that contain a provision whereby if we default on our indebtedness, and where repayment of the indebtedness has been accelerated by the lender, then we could also be declared in default on our derivative obligations. As of September 30, 2017 , the termination value of outstanding derivatives in a liability position, excluding any adjustment for non-performance risk, was $33.8 million . As of September 30, 2017 , we have no t posted any cash collateral related to these agreements. If we breach any of the default provisions on any of our indebtedness, as described above, we could be required to settle our obligations under the derivative agreements at their termination values.

Other, Net

Other, Net	9 Months Ended
	Sep. 30, 2017
Other Income and Expenses [Abstract]
Other, Net	Other, Net Other, net consisted of the following gains/(losses) for the three and nine months ended September 30, 2017 and 2016: For the three months ended For the nine months ended September 30, 2017 September 30, 2016 September 30, 2017 September 30, 2016 Currency remeasurement gain on net monetary assets $ 3,989 $ 1,707 $ 11,010 $ 550 Loss on foreign currency forward contracts (3,865 ) (3,827 ) (10,542 ) (7,912 ) Gain on commodity forward contracts 2,956 1,318 6,439 12,049 Other 32 76 283 205 Other, net $ 3,112 $ (726 ) $ 7,190 $ 4,892

Segment Reporting

Segment Reporting	9 Months Ended
	Sep. 30, 2017
Segment Reporting [Abstract]
Segment Reporting	Segment Reporting We organize our business into two reportable segments, Performance Sensing and Sensing Solutions, each of which is also an operating segment. Our operating segments are businesses that we manage as components of an enterprise, for which separate financial information is evaluated regularly by our chief operating decision maker in deciding how to allocate resources and assess performance. An operating segment’s performance is primarily evaluated based on Segment profit, which excludes amortization expense, restructuring and special charges, and certain corporate costs/credits not associated with the operations of the segment, including share-based compensation expense and a portion of depreciation expense associated with assets recorded in connection with acquisitions. In addition, an operating segment’s performance excludes results from discontinued operations, if any. Corporate costs excluded from an operating segment’s performance are separately stated below and also include costs that are related to functional areas, such as finance, information technology, legal, and human resources. We believe that Segment profit, as defined above, is an appropriate measure for evaluating the operating performance of our segments. However, this measure should be considered in addition to, and not as a substitute for, or superior to, profit from operations or other measures of financial performance prepared in accordance with U.S. GAAP. The accounting policies of each of our reporting segments are materially consistent with those in the summary of significant accounting policies as described in Note 2, "Significant Accounting Policies," included in our Annual Report on Form 10-K for the year ended December 31, 2016 . The following table presents Net revenue and Segment profit for the reported segments and other operating results not allocated to the reported segments for the three and nine months ended September 30, 2017 and 2016: For the three months ended For the nine months ended September 30, 2017 September 30, 2016 September 30, 2017 September 30, 2016 Net revenue: Performance Sensing $ 603,932 $ 584,650 $ 1,825,904 $ 1,797,395 Sensing Solutions 215,122 205,148 640,295 616,497 Total net revenue $ 819,054 $ 789,798 $ 2,466,199 $ 2,413,892 Segment profit (as defined above): Performance Sensing $ 162,655 $ 155,228 $ 483,491 $ 453,540 Sensing Solutions 72,372 67,314 209,911 198,737 Total segment profit 235,027 222,542 693,402 652,277 Corporate and other (53,379 ) (48,335 ) (152,681 ) (133,025 ) Amortization of intangible assets (40,317 ) (50,562 ) (121,578 ) (151,572 ) Restructuring and special charges (1,329 ) (837 ) (18,768 ) (3,167 ) Profit from operations 140,002 122,808 400,375 364,513 Interest expense, net (40,263 ) (41,176 ) (120,578 ) (125,201 ) Other, net 3,112 (726 ) 7,190 4,892 Income before taxes $ 102,851 $ 80,906 $ 286,987 $ 244,204

Net Income per Share

Net Income per Share	9 Months Ended
	Sep. 30, 2017
Earnings Per Share [Abstract]
Net Income per Share	Net Income per Share Basic and diluted net income per share are calculated by dividing Net income by the number of basic and diluted weighted-average ordinary shares outstanding during the period. For the three and nine months ended September 30, 2017 and 2016, the weighted-average ordinary shares outstanding for basic and diluted net income per share were as follows: For the three months ended For the nine months ended September 30, September 30, September 30, September 30, Basic weighted-average ordinary shares outstanding 171,269 170,840 171,116 170,656 Dilutive effect of stock options 618 431 567 504 Dilutive effect of unvested restricted securities 358 207 340 199 Diluted weighted-average ordinary shares outstanding 172,245 171,478 172,023 171,359 Net income and net income per share are presented in the condensed consolidated statements of operations. Certain potential ordinary shares were excluded from our calculation of diluted weighted-average ordinary shares outstanding because they would have had an anti-dilutive effect on net income per share or because they related to share-based awards that were contingently issuable, for which the contingency had not been satisfied. These potential ordinary shares are as follows: For the three months ended For the nine months ended September 30, September 30, September 30, September 30, Anti-dilutive shares excluded 1,584 1,355 1,635 1,418 Contingently issuable shares excluded 884 735 783 632

New Accounting Standards (Polic

New Accounting Standards (Policies)	9 Months Ended
	Sep. 30, 2017
New Accounting Pronouncements and Changes in Accounting Principles [Abstract]
Basis of Presentation	Basis of Presentation The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles ("U.S. GAAP") for interim financial information and the instructions to Form 10-Q. Accordingly, these interim financial statements do not include all of the information and note disclosures required by U.S. GAAP for complete financial statements. The accompanying financial information reflects all normal recurring adjustments that are, in the opinion of management, necessary for a fair presentation of the interim period results. The results of operations for the three and nine months ended September 30, 2017 are not necessarily indicative of the results to be expected for the full year, nor were the results of operations of the comparable periods in 2016 necessarily representative of those actually experienced for the full year 2016 . These unaudited condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and notes thereto included in our Annual Report on Form 10-K for the year ended December 31, 2016 . All intercompany balances and transactions have been eliminated. All U.S. dollar and share amounts presented, except per share amounts, are stated in thousands, unless otherwise indicated.
Reclassification	Certain reclassifications have been made to prior periods to conform to current period presentation
New Accounting Standards	New Accounting Standards In May 2014, the Financial Accounting Standards Board (the "FASB") issued Accounting Standards Update ("ASU") No. 2014-09, Revenue from Contracts with Customers (Topic 606) , which creates one Accounting Standards Codification ("ASC") Topic (FASB ASC 606, Revenue from Contracts with Customers ) that replaces the current guidance found in FASB ASC 605, Revenue Recognition , and various other revenue accounting standards for specialized transactions and industries. FASB ASU No. 2014-09 outlines a comprehensive five-step revenue recognition model based on the principle that an entity should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. FASB ASU No. 2014-09 may be applied using either a full retrospective approach, under which all years included in the financial statements will be presented under the revised guidance, or a modified retrospective approach, under which financial statements will be prepared under the revised guidance for the year of adoption, but not for prior years. Under the latter method, entities will recognize a cumulative catch-up adjustment to the opening balance of retained earnings at the effective date for contracts that still require performance by the entity. In August 2015, the FASB issued ASU No. 2015-14, Revenue from Contracts with Customers (Topic 606): Deferral of Effective Date, which defers the effective date of FASB ASU No. 2014-09 by one year. FASB ASU No. 2014-09 is now effective for annual reporting periods beginning after December 15, 2017, including interim periods within those annual reporting periods. We have developed an implementation plan to adopt this new guidance. As part of this plan, we are currently assessing the impact of the new guidance on our financial position and results of operations. Based on our procedures performed to date, nothing has come to our attention that would indicate that the adoption of FASB ASU No. 2014-09 will have a material impact on our financial position or results of operations. However, we will continue to evaluate this assessment through the remainder of 2017. In addition, the adoption of FASB ASU No. 2014-09 requires new disclosures related to revenue recognition, which we are continuing to evaluate. We intend to adopt FASB ASU No. 2014-09 on January 1, 2018 using the modified retrospective transition method. In February 2016, the FASB issued ASU No. 2016-02, Leases (Topic 842) , which establishes new accounting and disclosure requirements for leases. FASB ASU No. 2016-02 requires lessees to classify most leases as either finance or operating leases and to initially recognize a lease liability and right-of-use asset. Entities may elect to account for certain short-term leases (with a term of 12 months or less) using a method similar to the current operating lease model. The statements of operations will include, for finance leases, separate recognition of interest on the lease liability and amortization of the right-of-use asset and for operating leases, a single lease cost, calculated so that the cost of the lease is allocated over the lease term on a straight-line basis. At December 31, 2016, we were contractually obligated to make future payments of $69.8 million under our operating lease obligations in existence as of that date, primarily related to long-term facility leases. While we are in the early stages of our implementation process for FASB ASU No. 2016-02, and have not yet determined its impact on our consolidated financial statements, these leases would potentially be required to be presented on the balance sheet in accordance with the requirements of FASB ASU No. 2016-02. FASB ASU No. 2016-02 is effective for annual reporting periods beginning after December 15, 2018, including interim periods within those annual reporting periods, with early adoption permitted. FASB ASU No. 2016-02 must be applied using a modified retrospective approach, which requires recognition and measurement of leases at the beginning of the earliest period presented, with certain practical expedients available. In August 2017, the FASB issued ASU No. 2017-12, Derivatives and Hedging (Topic 815) , which changes both the designation and measurement guidance for qualifying hedging relationships and the presentation of hedge results, in order to better align an entity’s risk management activities and financial reporting for hedging relationships. The amendments expand and refine hedge accounting for both nonfinancial and financial risk components and align the recognition and presentation of the effects of the hedging instrument and the hedged item in the financial statements. FASB ASU No. 2017-12 is effective for annual reporting periods beginning after December 15, 2018, including interim periods within those annual reporting periods, with early adoption permitted. We are still evaluating the impact that this guidance will have on our consolidated financial statements, and we have not yet determined whether we will early adopt FASB ASU No. 2017-12.

Inventories (Tables)

Inventories (Tables)	9 Months Ended
	Sep. 30, 2017
Inventory Disclosure [Abstract]
Components of inventories	The components of inventories as of September 30, 2017 and December 31, 2016 were as follows: September 30, December 31, Finished goods $ 191,165 $ 169,304 Work-in-process 91,569 74,810 Raw materials 164,752 145,730 Inventories $ 447,486 $ 389,844

Shareholders' Equity (Tables)

Shareholders' Equity (Tables)	9 Months Ended
	Sep. 30, 2017
Equity [Abstract]
Roll forward of components of Accumulated other comprehensive loss, net of tax	The following is a roll forward of the components of Accumulated other comprehensive loss for the nine months ended September 30, 2017 : Cash Flow Hedges Defined Benefit and Retiree Healthcare Plans Accumulated Other Comprehensive Loss Balance as of December 31, 2016 $ 23 $ (34,090 ) $ (34,067 ) Other comprehensive loss before reclassifications, net of tax (25,078 ) — (25,078 ) Amounts reclassified from accumulated other comprehensive loss, net of tax 7,258 1,489 8,747 Net current period other comprehensive (loss)/income (17,820 ) 1,489 (16,331 ) Balance as of September 30, 2017 $ (17,797 ) $ (32,601 ) $ (50,398 )
Amounts reclassified from Accumulated other comprehensive loss	The details of the amounts reclassified from Accumulated other comprehensive loss for the three and nine months ended September 30, 2017 and 2016 are as follows: Amount of Loss/(Gain) Reclassified from Accumulated Other Comprehensive Loss Affected Line in Condensed Consolidated Statements of Operations For the three months ended For the nine months ended Component September 30, 2017 September 30, 2016 September 30, 2017 September 30, 2016 Derivative instruments designated and qualifying as cash flow hedges Foreign currency forward contracts $ 4,075 $ (2,771 ) $ (3,678 ) $ (15,075 ) Net revenue (1) Foreign currency forward contracts 1,953 4,834 13,356 14,857 Cost of revenue (1) Total, before taxes 6,028 2,063 9,678 (218 ) Income before taxes Income tax effect (1,507 ) (514 ) (2,420 ) 55 Provision for income taxes Total, net of taxes $ 4,521 $ 1,549 $ 7,258 $ (163 ) Net income Defined benefit and retiree healthcare plans $ 297 $ (5 ) $ 1,557 $ 324 Various (2) Income tax effect (23 ) 29 (68 ) (33 ) Provision for income taxes Total, net of taxes $ 274 $ 24 $ 1,489 $ 291 Net income (1) See Note 12, "Derivative Instruments and Hedging Activities," for additional details on amounts to be reclassified in the future from Accumulated other comprehensive loss. (2) Amounts related to defined benefit and retiree healthcare plans reclassified from Accumulated other comprehensive loss affect the Cost of revenue, Research and development, and Selling, general and administrative ("SG&A") expense line items in the condensed consolidated statements of operations. The amounts reclassified are included in the computation of net periodic benefit cost. See Note 8, "Pension and Other Post-Retirement Benefits," for additional details of net periodic benefit cost.

Restructuring and Special Cha25

Restructuring and Special Charges (Tables)	9 Months Ended
	Sep. 30, 2017
Restructuring and Related Activities [Abstract]
Changes to restructuring liability	Changes to the severance portion of our restructuring liability during the nine months ended September 30, 2017 were as follows: Severance Balance at December 31, 2016 $ 17,350 Charges, net of reversals 11,747 Payments (20,072 ) Impact of changes in foreign currency exchange rates 1,529 Balance at September 30, 2017 $ 10,554

Debt (Tables)

Debt (Tables)	9 Months Ended
	Sep. 30, 2017
Debt Disclosure [Abstract]
Schedule of long-term debt and capital lease and other financing obligations	Our long-term debt and capital lease and other financing obligations as of September 30, 2017 and December 31, 2016 consisted of the following: Maturity Date September 30, December 31, Term Loan October 14, 2021 $ 927,794 $ 937,794 4.875% Senior Notes October 15, 2023 500,000 500,000 5.625% Senior Notes November 1, 2024 400,000 400,000 5.0% Senior Notes October 1, 2025 700,000 700,000 6.25% Senior Notes February 15, 2026 750,000 750,000 Less: discount (15,812 ) (17,655 ) Less: deferred financing costs (29,971 ) (33,656 ) Less: current portion (7,327 ) (9,901 ) Long-term debt, net $ 3,224,684 $ 3,226,582 Capital lease and other financing obligations $ 35,839 $ 37,111 Less: current portion (5,849 ) (4,742 ) Capital lease and other financing obligations, less current portion $ 29,990 $ 32,369

Pension and Other Post-Retire27

Pension and Other Post-Retirement Benefits (Tables)	9 Months Ended
	Sep. 30, 2017
Retirement Benefits [Abstract]
Schedule of components of net periodic benefit cost	The components of net periodic benefit cost/(credit) associated with our defined benefit and retiree healthcare plans for the three months ended September 30, 2017 and 2016 were as follows: U.S. Plans Non-U.S. Plans Defined Benefit Retiree Healthcare Defined Benefit Total September 30, September 30, September 30, September 30, 2017 2016 2017 2016 2017 2016 2017 2016 Service cost $ — $ — $ 21 $ 25 $ 661 $ 697 $ 682 $ 722 Interest cost 385 332 80 94 273 298 738 724 Expected return on plan assets (527 ) (659 ) — — (230 ) (249 ) (757 ) (908 ) Amortization of net loss 291 118 8 46 64 42 363 206 Amortization of prior service (credit) — — (334 ) (334 ) (1 ) (18 ) (335 ) (352 ) Loss on settlement 269 140 — — — 1 269 141 Net periodic benefit cost/(credit) $ 418 $ (69 ) $ (225 ) $ (169 ) $ 767 $ 771 $ 960 $ 533 The components of net periodic benefit cost/(credit) associated with our defined benefit and retiree healthcare plans for the nine months ended September 30, 2017 and 2016 were as follows: U.S. Plans Non-U.S. Plans Defined Benefit Retiree Healthcare Defined Benefit Total September 30, September 30, September 30, September 30, 2017 2016 2017 2016 2017 2016 2017 2016 Service cost $ — $ — $ 64 $ 76 $ 1,917 $ 2,003 $ 1,981 $ 2,079 Interest cost 1,214 1,109 239 283 784 887 2,237 2,279 Expected return on plan assets (1,617 ) (2,006 ) — — (677 ) (714 ) (2,294 ) (2,720 ) Amortization of net loss 854 355 32 142 202 89 1,088 586 Amortization of prior service (credit)/cost — — (1,001 ) (1,001 ) (3 ) 8 (1,004 ) (993 ) Loss on settlement 1,473 730 — — — 1 1,473 731 Net periodic benefit cost/(credit) $ 1,924 $ 188 $ (666 ) $ (500 ) $ 2,223 $ 2,274 $ 3,481 $ 1,962

Share-Based Payment Plans (Tabl

Share-Based Payment Plans (Tables)	9 Months Ended
	Sep. 30, 2017
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
Schedule of non-cash compensation expense related to equity awards	The table below presents non-cash compensation expense related to our equity awards, which is recorded within SG&A expense in the condensed consolidated statements of operations, during the identified periods: For the three months ended For the nine months ended September 30, 2017 September 30, 2016 September 30, 2017 September 30, 2016 Stock options $ 1,575 $ 1,621 $ 5,055 $ 5,547 Restricted securities 3,522 3,136 10,051 7,732 Share-based compensation expense $ 5,097 $ 4,757 $ 15,106 $ 13,279
Schedule of options granted	We granted the following options under the Sensata Technologies Holding N.V. 2010 Equity Incentive Plan (the "2010 Equity Plan") during the nine months ended September 30, 2017 : Options Granted to Number of Options Granted (in thousands) Weighted- Average Grant Date Fair Value Vesting Period Various executives and employees 387 $14.50 25% per year over four years
Schedule of RSUs and PSUs	We granted the following RSUs and PRSUs under the 2010 Equity Plan during the nine months ended September 30, 2017 : Awards Granted to Type of Award Number of Units Granted (in thousands) Percentage of PRSUs Awarded That May Vest Weighted- Average Grant Date Fair Value Various executives and employees RSU (1) 147 N/A $43.67 Directors RSU (1) 34 N/A $41.10 Various executives and employees PRSU (2) 183 0.0% - 172.5% $43.67 Various executives and employees PRSU (2) 53 0.0% - 200.0% $43.33 (1) RSUs granted during the nine months ended September 30, 2017 vest on various dates between June 2018 and July 2020. (2) PRSUs granted during the nine months ended September 30, 2017 vest on various dates between April and May 2020, with the amount ultimately vesting within the range shown in the table above, dependent on the extent to which certain performance criteria are met.

Fair Value Measures (Tables)

Fair Value Measures (Tables)	9 Months Ended
	Sep. 30, 2017
Fair Value Disclosures [Abstract]
Schedule of assets and liabilities measured at fair value on a recurring basis	The following table presents information about our assets and liabilities measured at fair value on a recurring basis as of September 30, 2017 and December 31, 2016 , aggregated by the level in the fair value hierarchy within which those measurements fell: September 30, 2017 December 31, 2016 Quoted Prices in Active Markets for Identical Assets (Level 1) Significant Other Observable Inputs (Level 2) Significant Unobservable Inputs (Level 3) Quoted Prices in Active Markets for Identical Assets (Level 1) Significant Other Observable Inputs (Level 2) Significant Unobservable Inputs (Level 3) Assets Foreign currency forward contracts $ — $ 8,869 $ — $ — $ 32,757 $ — Commodity forward contracts — 4,847 — — 2,639 — Total $ — $ 13,716 $ — $ — $ 35,396 $ — Liabilities Foreign currency forward contracts $ — $ 31,911 $ — $ — $ 27,201 $ — Commodity forward contracts — 1,666 — — 3,790 — Total $ — $ 33,577 $ — $ — $ 30,991 $ —
Information about carrying values and fair values of financial instruments not recorded at fair value	The following table presents the carrying values and fair values of financial instruments not recorded at fair value in the condensed consolidated balance sheets as of September 30, 2017 and December 31, 2016 : September 30, 2017 December 31, 2016 Carrying Value (1) Fair Value Carrying Value (1) Fair Value Level 1 Level 2 Level 3 Level 1 Level 2 Level 3 Liabilities Term Loan $ 927,794 $ — $ 932,433 $ — $ 937,794 $ — $ 942,483 $ — 4.875% Senior Notes $ 500,000 $ — $ 525,000 $ — $ 500,000 $ — $ 514,375 $ — 5.625% Senior Notes $ 400,000 $ — $ 440,000 $ — $ 400,000 $ — $ 417,752 $ — 5.0% Senior Notes $ 700,000 $ — $ 736,750 $ — $ 700,000 $ — $ 686,000 $ — 6.25% Senior Notes $ 750,000 $ — $ 819,375 $ — $ 750,000 $ — $ 786,098 $ — (1) Carrying value excludes discounts and deferred financing costs.

Derivative Instruments and He30

Derivative Instruments and Hedging Activities (Tables)	9 Months Ended
	Sep. 30, 2017
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Schedule of outstanding derivative instruments	As of September 30, 2017 , we had the following outstanding foreign currency forward contracts: Notional (in millions) Effective Date(s) Maturity Date(s) Index Weighted- Average Strike Rate Hedge Designation 65.0 EUR September 27, 2017 October 31, 2017 Euro to U.S. Dollar Exchange Rate 1.18 USD Not designated 461.6 EUR Various from April 2015 to September 2017 Various from October 2017 to December 2019 Euro to U.S. Dollar Exchange Rate 1.14 USD Designated 500.0 CNY September 26, 2017 October 31, 2017 U.S. Dollar to Chinese Renminbi Exchange Rate 6.68 CNY Not designated 132.0 CNY Various in February 2017 Various from October to December 2017 U.S. Dollar to Chinese Renminbi Exchange Rate 7.05 CNY Designated 110.0 JPY September 27, 2017 October 31, 2017 U.S. Dollar to Japanese Yen Exchange Rate 112.80 JPY Not designated 237.0 JPY January 5, 2017 Various from October to December 2017 U.S. Dollar to Japanese Yen Exchange Rate 113.71 JPY Designated 45,258.3 KRW Various from April 2015 to September 2017 Various from October 2017 to August 2019 U.S. Dollar to Korean Won Exchange Rate 1,140.77 KRW Designated 36.5 MYR Various from April 2015 to November 2016 Various from October 2017 to October 2018 U.S. Dollar to Malaysian Ringgit Exchange Rate 4.19 MYR Designated 182.0 MXN September 27, 2017 October 31, 2017 U.S. Dollar to Mexican Peso Exchange Rate 18.24 MXN Not designated 2,166.8 MXN Various from April 2015 to September 2017 Various from October 2017 to August 2019 U.S. Dollar to Mexican Peso Exchange Rate 19.94 MXN Designated 44.5 GBP Various from April 2015 to September 2017 Various from October 2017 to August 2019 British Pound Sterling to U.S. Dollar Exchange Rate 1.33 USD Designated We had the following outstanding commodity forward contracts, none of which were designated as derivatives in qualifying hedging relationships, as of September 30, 2017 : Commodity Notional Remaining Contracted Periods Weighted-Average Strike Price Per Unit Silver 1,109,455 troy oz. October 2017 - August 2019 $17.69 Gold 12,150 troy oz. October 2017 - August 2019 $1,269.40 Nickel 287,659 pounds October 2017 - August 2019 $4.68 Aluminum 5,554,370 pounds October 2017 - August 2019 $0.84 Copper 7,394,018 pounds October 2017 - August 2019 $2.54 Platinum 8,036 troy oz. October 2017 - August 2019 $996.80 Palladium 1,927 troy oz. October 2017 - August 2019 $759.11
Schedule of fair values of derivative financial instruments and their classification in balance sheets	The following table presents the fair values of our derivative financial instruments and their classification in the condensed consolidated balance sheets as of September 30, 2017 and December 31, 2016 : Asset Derivatives Liability Derivatives Fair Value Fair Value Balance Sheet Location September 30, 2017 December 31, 2016 Balance Sheet Location September 30, 2017 December 31, 2016 Derivatives designated as hedging instruments Foreign currency forward contracts Prepaid expenses and other current assets $ 6,909 $ 24,796 Accrued expenses and other current liabilities $ 23,838 $ 20,990 Foreign currency forward contracts Other assets 1,956 5,693 Other long-term liabilities 7,327 3,814 Total $ 8,865 $ 30,489 $ 31,165 $ 24,804 Derivatives not designated as hedging instruments Commodity forward contracts Prepaid expenses and other current assets $ 4,173 $ 2,097 Accrued expenses and other current liabilities $ 1,400 $ 2,764 Commodity forward contracts Other assets 674 542 Other long-term liabilities 266 1,026 Foreign currency forward contracts Prepaid expenses and other current assets 4 2,268 Accrued expenses and other current liabilities 746 2,397 Total $ 4,851 $ 4,907 $ 2,412 $ 6,187
Schedule of effect of derivative financial instruments on statements of operations	The following tables present the effect of our derivative financial instruments on the condensed consolidated statements of operations for the three months ended September 30, 2017 and 2016: Derivatives designated as hedging instruments Amount of Deferred (Loss)/Gain Recognized in Other Comprehensive Loss Location of Net (Loss)/Gain Reclassified from Accumulated Other Comprehensive Loss into Net Income Amount of Net (Loss)/Gain Reclassified from Accumulated Other Comprehensive Loss into Net Income September 30, 2017 September 30, 2016 September 30, 2017 September 30, 2016 Foreign currency forward contracts $ (16,688 ) $ (6,929 ) Net revenue $ (4,075 ) $ 2,771 Foreign currency forward contracts $ 1,614 $ (6,450 ) Cost of revenue $ (1,953 ) $ (4,834 ) Derivatives not designated as hedging instruments Amount of Gain/(Loss) Recognized in Net Income Location of Gain/(Loss) Recognized in Net Income September 30, 2017 September 30, 2016 Commodity forward contracts $ 2,956 $ 1,318 Other, net Foreign currency forward contracts $ (3,865 ) $ (3,827 ) Other, net The following tables present the effect of our derivative financial instruments on the condensed consolidated statements of operations for the nine months ended September 30, 2017 and 2016: Derivatives designated as hedging instruments Amount of Deferred (Loss)/Gain Recognized in Other Comprehensive Loss Location of Net Gain/(Loss) Reclassified from Accumulated Other Comprehensive Loss into Net Income Amount of Net Gain/(Loss) Reclassified from Accumulated Other Comprehensive Loss into Net Income September 30, 2017 September 30, 2016 September 30, 2017 September 30, 2016 Foreign currency forward contracts $ (56,479 ) $ (12,810 ) Net revenue $ 3,678 $ 15,075 Foreign currency forward contracts $ 23,041 $ (20,319 ) Cost of revenue $ (13,356 ) $ (14,857 ) Derivatives not designated as hedging instruments Amount of Gain/(Loss) Recognized in Net Income Location of Gain/(Loss) Recognized in Net Income September 30, 2017 September 30, 2016 Commodity forward contracts $ 6,439 $ 12,049 Other, net Foreign currency forward contracts $ (10,542 ) $ (7,912 ) Other, net

Other, Net (Tables)

Other, Net (Tables)	9 Months Ended
	Sep. 30, 2017
Other Income and Expenses [Abstract]
Schedule of other, net	Other, net consisted of the following gains/(losses) for the three and nine months ended September 30, 2017 and 2016: For the three months ended For the nine months ended September 30, 2017 September 30, 2016 September 30, 2017 September 30, 2016 Currency remeasurement gain on net monetary assets $ 3,989 $ 1,707 $ 11,010 $ 550 Loss on foreign currency forward contracts (3,865 ) (3,827 ) (10,542 ) (7,912 ) Gain on commodity forward contracts 2,956 1,318 6,439 12,049 Other 32 76 283 205 Other, net $ 3,112 $ (726 ) $ 7,190 $ 4,892

Segment Reporting (Tables)

Segment Reporting (Tables)	9 Months Ended
	Sep. 30, 2017
Segment Reporting [Abstract]
Schedule of segment reporting information by segment	The following table presents Net revenue and Segment profit for the reported segments and other operating results not allocated to the reported segments for the three and nine months ended September 30, 2017 and 2016: For the three months ended For the nine months ended September 30, 2017 September 30, 2016 September 30, 2017 September 30, 2016 Net revenue: Performance Sensing $ 603,932 $ 584,650 $ 1,825,904 $ 1,797,395 Sensing Solutions 215,122 205,148 640,295 616,497 Total net revenue $ 819,054 $ 789,798 $ 2,466,199 $ 2,413,892 Segment profit (as defined above): Performance Sensing $ 162,655 $ 155,228 $ 483,491 $ 453,540 Sensing Solutions 72,372 67,314 209,911 198,737 Total segment profit 235,027 222,542 693,402 652,277 Corporate and other (53,379 ) (48,335 ) (152,681 ) (133,025 ) Amortization of intangible assets (40,317 ) (50,562 ) (121,578 ) (151,572 ) Restructuring and special charges (1,329 ) (837 ) (18,768 ) (3,167 ) Profit from operations 140,002 122,808 400,375 364,513 Interest expense, net (40,263 ) (41,176 ) (120,578 ) (125,201 ) Other, net 3,112 (726 ) 7,190 4,892 Income before taxes $ 102,851 $ 80,906 $ 286,987 $ 244,204

Net Income per Share (Tables)

Net Income per Share (Tables)	9 Months Ended
	Sep. 30, 2017
Earnings Per Share [Abstract]
Schedule of weighted-average ordinary shares outstanding	For the three and nine months ended September 30, 2017 and 2016, the weighted-average ordinary shares outstanding for basic and diluted net income per share were as follows: For the three months ended For the nine months ended September 30, September 30, September 30, September 30, Basic weighted-average ordinary shares outstanding 171,269 170,840 171,116 170,656 Dilutive effect of stock options 618 431 567 504 Dilutive effect of unvested restricted securities 358 207 340 199 Diluted weighted-average ordinary shares outstanding 172,245 171,478 172,023 171,359
Schedule of antidilutive securities	These potential ordinary shares are as follows: For the three months ended For the nine months ended September 30, September 30, September 30, September 30, Anti-dilutive shares excluded 1,584 1,355 1,635 1,418 Contingently issuable shares excluded 884 735 783 632

Business Description and Basi34

Business Description and Basis of Presentation (Details)	9 Months Ended
	Sep. 30, 2017segment
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Number of businesses	2

New Accounting Standards (Detai

New Accounting Standards (Details) $ in Millions	Dec. 31, 2016USD ($)
New Accounting Pronouncements and Changes in Accounting Principles [Abstract]
Future payments	$ 69.8

Inventories (Details)

Inventories (Details) - USD ($) $ in Thousands	Sep. 30, 2017	Dec. 31, 2016
Inventory, Net [Abstract]
Finished goods	$ 191,165	$ 169,304
Work-in-process	91,569	74,810
Raw materials	164,752	145,730
Inventories	$ 447,486	$ 389,844

Shareholders' Equity - Narrativ

Shareholders' Equity - Narrative (Details) shares in Millions, $ in Millions	9 Months Ended
	Sep. 30, 2017USD ($)shares
Equity [Abstract]
Reissued treasury shares (in shares) | shares	0.5
Treasury stock, loss from reissuances | $	$ 13.1

Shareholders' Equity - AOCI Rol

Shareholders' Equity - AOCI Roll Forward (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2017	Sep. 30, 2016	Sep. 30, 2017	Sep. 30, 2016
Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward]
Balance as of December 31, 2016			$ 1,942,007
Other comprehensive loss before reclassifications, net of tax			(25,078)
Amounts reclassified from accumulated other comprehensive loss, net of tax			8,747
Other comprehensive loss	$ (6,510)	$ (8,461)	(16,331)	$ (24,719)
Balance as of September 30, 2017	2,182,525		2,182,525
Cash Flow Hedges
Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward]
Balance as of December 31, 2016			23
Other comprehensive loss before reclassifications, net of tax			(25,078)
Amounts reclassified from accumulated other comprehensive loss, net of tax			7,258
Other comprehensive loss			(17,820)
Balance as of September 30, 2017	(17,797)		(17,797)
Defined Benefit and Retiree Healthcare Plans
Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward]
Balance as of December 31, 2016			(34,090)
Other comprehensive loss before reclassifications, net of tax			0
Amounts reclassified from accumulated other comprehensive loss, net of tax	274	$ 24	1,489	$ 291
Other comprehensive loss			1,489
Balance as of September 30, 2017	(32,601)		(32,601)
Accumulated Other Comprehensive Loss
Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward]
Balance as of December 31, 2016			(34,067)
Balance as of September 30, 2017	$ (50,398)		$ (50,398)

Shareholders' Equity - AOCI Rec

Shareholders' Equity - AOCI Reclassifications (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2017	Sep. 30, 2016	Sep. 30, 2017	Sep. 30, 2016
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Net revenue	$ 819,054	$ 789,798	$ 2,466,199	$ 2,413,892
Cost of revenue	(527,432)	(508,944)	(1,601,190)	(1,574,763)
Income before taxes	102,851	80,906	286,987	244,204
Provision for income taxes	(14,816)	(11,121)	(47,759)	(48,297)
Net income	88,035	69,785	239,228	195,907
Total, net of taxes			8,747
Derivative instruments designated and qualifying as cash flow hedges
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Total, net of taxes			7,258
Defined benefit and retiree healthcare plans
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Defined benefit and retiree healthcare plans	297	(5)	1,557	324
Provision for income taxes	(23)	29	(68)	(33)
Total, net of taxes	274	24	1,489	291
Amount of Loss/(Gain) Reclassified from Accumulated Other Comprehensive Loss | Derivative instruments designated and qualifying as cash flow hedges
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Income before taxes	6,028	2,063	9,678	(218)
Provision for income taxes	(1,507)	(514)	(2,420)	55
Net income	4,521	1,549	7,258	(163)
Amount of Loss/(Gain) Reclassified from Accumulated Other Comprehensive Loss | Derivative instruments designated and qualifying as cash flow hedges | Foreign currency forward contracts
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Net revenue	4,075	(2,771)	(3,678)	(15,075)
Cost of revenue	$ 1,953	$ 4,834	$ 13,356	$ 14,857

Restructuring and Special Cha40

Restructuring and Special Charges (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2017	Sep. 30, 2016	Sep. 30, 2017	Sep. 30, 2016
Restructuring Cost and Reserve [Line Items]
Restructuring and special charges	$ 1,329	$ 837	$ 18,768	$ 3,167
Severance
Restructuring Reserve [Roll Forward]
Beginning Balance			17,350
Charges, net of reversals			11,747
Payments			(20,072)
Impact of changes in foreign currency exchange rates			1,529
Ending Balance	10,554		10,554
Facility Closing, Minden, Germany
Restructuring Cost and Reserve [Line Items]
Severance charges	0		8,400
Facility exit costs	$ 1,300		$ 2,400

Debt - Debt Schedule (Details)

Debt - Debt Schedule (Details) - USD ($) $ in Thousands	Sep. 30, 2017	Dec. 31, 2016
Debt Instrument [Line Items]
Less: discount	$ (15,812)	$ (17,655)
Less: deferred financing costs	(29,971)	(33,656)
Less: current portion	(7,327)	(9,901)
Long-term debt, net	3,224,684	3,226,582
Capital lease and other financing obligations	35,839	37,111
Less: current portion	(5,849)	(4,742)
Capital lease and other financing obligations, less current portion	29,990	32,369
Term Loan
Debt Instrument [Line Items]
Gross long-term debt	927,794	937,794
4.875% Senior Notes
Debt Instrument [Line Items]
Gross long-term debt	$ 500,000	500,000
Stated interest rate	4.875%
5.625% Senior Notes
Debt Instrument [Line Items]
Gross long-term debt	$ 400,000	400,000
Stated interest rate	5.625%
5.0% Senior Notes
Debt Instrument [Line Items]
Gross long-term debt	$ 700,000	700,000
Stated interest rate	5.00%
6.25% Senior Notes
Debt Instrument [Line Items]
Gross long-term debt	$ 750,000	$ 750,000
Stated interest rate	6.25%

Debt - Narrative (Details)

Debt - Narrative (Details) - USD ($)	Sep. 30, 2017	Dec. 31, 2016
Debt Instrument [Line Items]
Accrued interest	$ 45,700,000	$ 36,800,000
Revolving Credit Facility
Debt Instrument [Line Items]
Amount available under revolving credit facility	415,300,000
Maximum borrowing capacity	420,000,000
Letters of credit outstanding, amount	4,700,000
Letter of Credit
Debt Instrument [Line Items]
Letters of credit outstanding, amount	$ 0

Income Taxes (Details)

Income Taxes (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2017	Sep. 30, 2016	Sep. 30, 2017	Sep. 30, 2016
Valuation Allowance [Line Items]
Provision for income taxes	$ 14,816	$ 11,121	$ 47,759	$ 48,297
CST
Valuation Allowance [Line Items]
Recognized benefit from income taxes		$ 5,100		$ 3,700

Pension and Other Post-Retire44

Pension and Other Post-Retirement Benefits (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2017	Sep. 30, 2016	Sep. 30, 2017	Sep. 30, 2016
Defined Benefit Plan, Net Periodic Benefit Cost (Credit) [Abstract]
Service cost	$ 682	$ 722	$ 1,981	$ 2,079
Interest cost	738	724	2,237	2,279
Expected return on plan assets	(757)	(908)	(2,294)	(2,720)
Amortization of net loss	363	206	1,088	586
Amortization of prior service (credit)/cost	(335)	(352)	(1,004)	(993)
Loss on settlement	269	141	1,473	731
Net periodic benefit cost/(credit)	960	533	3,481	1,962
U.S. Plans | Defined Benefit
Defined Benefit Plan, Net Periodic Benefit Cost (Credit) [Abstract]
Service cost	0	0	0	0
Interest cost	385	332	1,214	1,109
Expected return on plan assets	(527)	(659)	(1,617)	(2,006)
Amortization of net loss	291	118	854	355
Amortization of prior service (credit)/cost	0	0	0	0
Loss on settlement	269	140	1,473	730
Net periodic benefit cost/(credit)	418	(69)	1,924	188
U.S. Plans | Retiree Healthcare
Defined Benefit Plan, Net Periodic Benefit Cost (Credit) [Abstract]
Service cost	21	25	64	76
Interest cost	80	94	239	283
Expected return on plan assets	0	0	0	0
Amortization of net loss	8	46	32	142
Amortization of prior service (credit)/cost	(334)	(334)	(1,001)	(1,001)
Loss on settlement	0	0	0	0
Net periodic benefit cost/(credit)	(225)	(169)	(666)	(500)
Non-U.S. Plans | Defined Benefit
Defined Benefit Plan, Net Periodic Benefit Cost (Credit) [Abstract]
Service cost	661	697	1,917	2,003
Interest cost	273	298	784	887
Expected return on plan assets	(230)	(249)	(677)	(714)
Amortization of net loss	64	42	202	89
Amortization of prior service (credit)/cost	(1)	(18)	(3)	8
Loss on settlement	0	1	0	1
Net periodic benefit cost/(credit)	$ 767	$ 771	$ 2,223	$ 2,274

Share-Based Payment Plans - Sch

Share-Based Payment Plans - Schedule of Non-Cash Compensation Expense Related to Equity Awards (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2017	Sep. 30, 2016	Sep. 30, 2017	Sep. 30, 2016
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based compensation expense	$ 5,097	$ 4,757	$ 15,106	$ 13,279
Stock options
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based compensation expense	1,575	1,621	5,055	5,547
Restricted securities
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based compensation expense	$ 3,522	$ 3,136	$ 10,051	$ 7,732

Share-Based Payment Plans - S46

Share-Based Payment Plans - Schedule of Options Granted (Details) - Various executives and employees - Stock options - 25% per year over four years shares in Thousands	9 Months Ended
	Sep. 30, 2017$ / sharesshares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of Options Granted (in shares) | shares	387
Weighted- Average Grant Date Fair Value (in dollars per share) | $ / shares	$ 14.50
Vesting period	4 years
Vesting percent	25.00%

Share-Based Payment Plans - S47

Share-Based Payment Plans - Schedule of RSUs and PSUs (Details) shares in Thousands	9 Months Ended
	Sep. 30, 2017$ / sharesshares
Various executives and employees | RSU
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of Options Granted (in shares) | shares	147
Weighted-Average Grant Date Fair Value (in dollars per share) | $ / shares	$ 43.67
Directors | RSU
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of Options Granted (in shares) | shares	34
Weighted-Average Grant Date Fair Value (in dollars per share) | $ / shares	$ 41.10
0.0% - 172.5% | Various executives and employees | PRSU
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of Options Granted (in shares) | shares	183
Weighted-Average Grant Date Fair Value (in dollars per share) | $ / shares	$ 43.67
0.0% - 200.0% | Various executives and employees | PRSU
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of Options Granted (in shares) | shares	53
Weighted-Average Grant Date Fair Value (in dollars per share) | $ / shares	$ 43.33
Minimum | 0.0% - 172.5% | Various executives and employees | PRSU
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting percent	0.00%
Minimum | 0.0% - 200.0% | Various executives and employees | PRSU
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting percent	0.00%
Maximum | 0.0% - 172.5% | Various executives and employees | PRSU
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting percent	172.50%
Maximum | 0.0% - 200.0% | Various executives and employees | PRSU
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting percent	200.00%

Share-Based Payment Plans - Nar

Share-Based Payment Plans - Narrative (Details) shares in Thousands	9 Months Ended
	Sep. 30, 2017shares
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
Option exercised, shares	266

Fair Value Measures - Schedule

Fair Value Measures - Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis (Details) - USD ($) $ in Thousands	Sep. 30, 2017	Dec. 31, 2016
Quoted Prices in Active Markets for Identical Assets (Level 1)
Assets
Assets	$ 0	$ 0
Liabilities
Liabilities	0	0
Quoted Prices in Active Markets for Identical Assets (Level 1) | Foreign currency forward contracts
Assets
Assets	0	0
Liabilities
Liabilities	0	0
Quoted Prices in Active Markets for Identical Assets (Level 1) | Commodity forward contracts
Assets
Assets	0	0
Liabilities
Liabilities	0	0
Significant Other Observable Inputs (Level 2)
Assets
Assets	13,716	35,396
Liabilities
Liabilities	33,577	30,991
Significant Other Observable Inputs (Level 2) | Foreign currency forward contracts
Assets
Assets	8,869	32,757
Liabilities
Liabilities	31,911	27,201
Significant Other Observable Inputs (Level 2) | Commodity forward contracts
Assets
Assets	4,847	2,639
Liabilities
Liabilities	1,666	3,790
Significant Unobservable Inputs (Level 3)
Assets
Assets	0	0
Liabilities
Liabilities	0	0
Significant Unobservable Inputs (Level 3) | Foreign currency forward contracts
Assets
Assets	0	0
Liabilities
Liabilities	0	0
Significant Unobservable Inputs (Level 3) | Commodity forward contracts
Assets
Assets	0	0
Liabilities
Liabilities	$ 0	$ 0

Fair Value Measures - Narrative

Fair Value Measures - Narrative (Details) - USD ($) $ in Millions	1 Months Ended
	Mar. 31, 2016	Mar. 31, 2017
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Facility recorded as held for sale		$ 1.7
Quanergy | Series B Preferred Stock
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Value of Series B Preferred Stock acquired	$ 50

Fair Value Measures - Fair Valu

Fair Value Measures - Fair Value, by Balance Sheet Grouping (Details) - USD ($) $ in Thousands	Sep. 30, 2017	Dec. 31, 2016
Term Loan | Carrying Value
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Fair Value	$ 927,794	$ 937,794
Term Loan | Level 1
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Fair Value	0	0
Term Loan | Level 2
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Fair Value	932,433	942,483
Term Loan | Level 3
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Fair Value	$ 0	0
4.875% Senior Notes
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Stated interest rate	4.875%
4.875% Senior Notes | Carrying Value
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Fair Value	$ 500,000	500,000
4.875% Senior Notes | Level 1
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Fair Value	0	0
4.875% Senior Notes | Level 2
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Fair Value	525,000	514,375
4.875% Senior Notes | Level 3
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Fair Value	$ 0	0
5.625% Senior Notes
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Stated interest rate	5.625%
5.625% Senior Notes | Carrying Value
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Fair Value	$ 400,000	400,000
5.625% Senior Notes | Level 1
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Fair Value	0	0
5.625% Senior Notes | Level 2
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Fair Value	440,000	417,752
5.625% Senior Notes | Level 3
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Fair Value	$ 0	0
5.0% Senior Notes
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Stated interest rate	5.00%
5.0% Senior Notes | Carrying Value
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Fair Value	$ 700,000	700,000
5.0% Senior Notes | Level 1
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Fair Value	0	0
5.0% Senior Notes | Level 2
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Fair Value	736,750	686,000
5.0% Senior Notes | Level 3
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Fair Value	$ 0	0
6.25% Senior Notes
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Stated interest rate	6.25%
6.25% Senior Notes | Carrying Value
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Fair Value	$ 750,000	750,000
6.25% Senior Notes | Level 1
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Fair Value	0	0
6.25% Senior Notes | Level 2
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Fair Value	819,375	786,098
6.25% Senior Notes | Level 3
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Fair Value	$ 0	$ 0

Derivative Instruments and He52

Derivative Instruments and Hedging Activities - Narrative (Details) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2017	Sep. 30, 2016	Sep. 30, 2017	Sep. 30, 2016
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Amounts excluded from foreign currency cash flow ineffectiveness assessment	$ 0	$ 0	$ 0	$ 0
Foreign currency cash flow loss to be reclassified during next 12 months	18,400,000		18,400,000
Termination value of outstanding derivatives in a liability position	33,800,000		33,800,000
Collateral already posted, aggregate fair value	$ 0		$ 0

Derivative Instruments and He53

Derivative Instruments and Hedging Activities - Schedule of Derivative Instruments (Details) - Sep. 30, 2017 € in Millions, ₩ in Millions, ¥ in Millions, ¥ in Millions, £ in Millions, MYR in Millions, MXN in Millions	EUR (€)oztlb$ / lb$ / ozt$ / MXN$ / ¥€ / $$ / MYR$ / ¥£ / $$ / ₩	KRW (₩)oztlb$ / lb$ / ozt$ / MXN$ / ¥€ / $$ / MYR$ / ¥£ / $$ / ₩	MXNoztlb$ / lb$ / ozt$ / MXN$ / ¥€ / $$ / MYR$ / ¥£ / $$ / ₩	GBP (£)oztlb$ / lb$ / ozt$ / MXN$ / ¥€ / $$ / MYR$ / ¥£ / $$ / ₩	CNY (¥)oztlb$ / lb$ / ozt$ / MXN$ / ¥€ / $$ / MYR$ / ¥£ / $$ / ₩	MYRoztlb$ / lb$ / ozt$ / MXN$ / ¥€ / $$ / MYR$ / ¥£ / $$ / ₩	JPY (¥)oztlb$ / lb$ / ozt$ / MXN$ / ¥€ / $$ / MYR$ / ¥£ / $$ / ₩
Foreign currency forward contracts | Not designated | Euro to U.S. Dollar Exchange Rate
Hedges of Foreign Currency Risk
Notional amount of derivatives | €	€ 65
Weighted-Average Strike Rate | € / $	1.18	1.18	1.18	1.18	1.18	1.18	1.18
Foreign currency forward contracts | Not designated | U.S. Dollar to Chinese Renminbi Exchange Rate
Hedges of Foreign Currency Risk
Notional amount of derivatives | ¥					¥ 500
Weighted-Average Strike Rate | $ / ¥	6.68	6.68	6.68	6.68	6.68	6.68	6.68
Foreign currency forward contracts | Not designated | U.S. Dollar to Japanese Yen Exchange Rate
Hedges of Foreign Currency Risk
Notional amount of derivatives | ¥							¥ 110
Weighted-Average Strike Rate | $ / ¥	112.80	112.80	112.80	112.80	112.80	112.80	112.80
Foreign currency forward contracts | Not designated | U.S. Dollar to Mexican Peso Exchange Rate
Hedges of Foreign Currency Risk
Notional amount of derivatives | MXN			MXN 182
Weighted-Average Strike Rate | $ / MXN	18.24	18.24	18.24	18.24	18.24	18.24	18.24
Foreign currency forward contracts | Designated | Euro to U.S. Dollar Exchange Rate
Hedges of Foreign Currency Risk
Notional amount of derivatives | €	€ 461.6
Weighted-Average Strike Rate | € / $	1.14	1.14	1.14	1.14	1.14	1.14	1.14
Foreign currency forward contracts | Designated | U.S. Dollar to Chinese Renminbi Exchange Rate
Hedges of Foreign Currency Risk
Notional amount of derivatives | ¥					¥ 132
Weighted-Average Strike Rate | $ / ¥	7.05	7.05	7.05	7.05	7.05	7.05	7.05
Foreign currency forward contracts | Designated | U.S. Dollar to Japanese Yen Exchange Rate
Hedges of Foreign Currency Risk
Notional amount of derivatives | ¥							¥ 237
Weighted-Average Strike Rate | $ / ¥	113.71	113.71	113.71	113.71	113.71	113.71	113.71
Foreign currency forward contracts | Designated | U.S. Dollar to Korean Won Exchange Rate
Hedges of Foreign Currency Risk
Notional amount of derivatives | ₩		₩ 45,258.3
Weighted-Average Strike Rate | $ / ₩	1,140.77	1,140.77	1,140.77	1,140.77	1,140.77	1,140.77	1,140.77
Foreign currency forward contracts | Designated | U.S. Dollar to Malaysian Ringgit Exchange Rate
Hedges of Foreign Currency Risk
Notional amount of derivatives | MYR						MYR 36.5
Weighted-Average Strike Rate | $ / MYR	4.19	4.19	4.19	4.19	4.19	4.19	4.19
Foreign currency forward contracts | Designated | U.S. Dollar to Mexican Peso Exchange Rate
Hedges of Foreign Currency Risk
Notional amount of derivatives | MXN			MXN 2,166.8
Weighted-Average Strike Rate | $ / MXN	19.94	19.94	19.94	19.94	19.94	19.94	19.94
Foreign currency forward contracts | Designated | British Pound Sterling to U.S. Dollar Exchange Rate
Hedges of Foreign Currency Risk
Notional amount of derivatives | £				£ 44.5
Weighted-Average Strike Rate | £ / $	1.33	1.33	1.33	1.33	1.33	1.33	1.33
Silver | Not designated
Hedges of Commodity Risk
Notional | ozt	1,109,455	1,109,455	1,109,455	1,109,455	1,109,455	1,109,455	1,109,455
Weighted-Average Strike Price Per Unit (in dollars per unit) | $ / ozt	17.69	17.69	17.69	17.69	17.69	17.69	17.69
Gold | Not designated
Hedges of Commodity Risk
Notional | ozt	12,150	12,150	12,150	12,150	12,150	12,150	12,150
Weighted-Average Strike Price Per Unit (in dollars per unit) | $ / ozt	1,269.40	1,269.40	1,269.40	1,269.40	1,269.40	1,269.40	1,269.40
Nickel | Not designated
Hedges of Commodity Risk
Notional | lb	287,659	287,659	287,659	287,659	287,659	287,659	287,659
Weighted-Average Strike Price Per Unit (in dollars per unit) | $ / lb	4.68	4.68	4.68	4.68	4.68	4.68	4.68
Aluminum | Not designated
Hedges of Commodity Risk
Notional | lb	5,554,370	5,554,370	5,554,370	5,554,370	5,554,370	5,554,370	5,554,370
Weighted-Average Strike Price Per Unit (in dollars per unit) | $ / lb	0.84	0.84	0.84	0.84	0.84	0.84	0.84
Copper | Not designated
Hedges of Commodity Risk
Notional | lb	7,394,018	7,394,018	7,394,018	7,394,018	7,394,018	7,394,018	7,394,018
Weighted-Average Strike Price Per Unit (in dollars per unit) | $ / lb	2.54	2.54	2.54	2.54	2.54	2.54	2.54
Platinum | Not designated
Hedges of Commodity Risk
Notional | ozt	8,036	8,036	8,036	8,036	8,036	8,036	8,036
Weighted-Average Strike Price Per Unit (in dollars per unit) | $ / ozt	996.80	996.80	996.80	996.80	996.80	996.80	996.80
Palladium | Not designated
Hedges of Commodity Risk
Notional | ozt	1,927	1,927	1,927	1,927	1,927	1,927	1,927
Weighted-Average Strike Price Per Unit (in dollars per unit) | $ / ozt	759.11	759.11	759.11	759.11	759.11	759.11	759.11

Derivative Instruments and He54

Derivative Instruments and Hedging Activities - Fair Value (Details) - USD ($) $ in Thousands	Sep. 30, 2017	Dec. 31, 2016
Designated
Derivatives, Fair Value [Line Items]
Asset Derivatives, Fair Value	$ 8,865	$ 30,489
Liability Derivatives, Fair Value	31,165	24,804
Not designated
Derivatives, Fair Value [Line Items]
Asset Derivatives, Fair Value	4,851	4,907
Liability Derivatives, Fair Value	2,412	6,187
Foreign currency forward contracts | Designated | Prepaid expenses and other current assets
Derivatives, Fair Value [Line Items]
Asset Derivatives, Fair Value	6,909	24,796
Foreign currency forward contracts | Designated | Other assets
Derivatives, Fair Value [Line Items]
Asset Derivatives, Fair Value	1,956	5,693
Foreign currency forward contracts | Designated | Accrued expenses and other current liabilities
Derivatives, Fair Value [Line Items]
Liability Derivatives, Fair Value	23,838	20,990
Foreign currency forward contracts | Designated | Other long-term liabilities
Derivatives, Fair Value [Line Items]
Liability Derivatives, Fair Value	7,327	3,814
Foreign currency forward contracts | Not designated | Prepaid expenses and other current assets
Derivatives, Fair Value [Line Items]
Asset Derivatives, Fair Value	4	2,268
Foreign currency forward contracts | Not designated | Accrued expenses and other current liabilities
Derivatives, Fair Value [Line Items]
Liability Derivatives, Fair Value	746	2,397
Commodity forward contracts | Not designated | Prepaid expenses and other current assets
Derivatives, Fair Value [Line Items]
Asset Derivatives, Fair Value	4,173	2,097
Commodity forward contracts | Not designated | Other assets
Derivatives, Fair Value [Line Items]
Asset Derivatives, Fair Value	674	542
Commodity forward contracts | Not designated | Accrued expenses and other current liabilities
Derivatives, Fair Value [Line Items]
Liability Derivatives, Fair Value	1,400	2,764
Commodity forward contracts | Not designated | Other long-term liabilities
Derivatives, Fair Value [Line Items]
Liability Derivatives, Fair Value	$ 266	$ 1,026

Derivative Instruments and He55

Derivative Instruments and Hedging Activities - Income Statement Disclosures (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2017	Sep. 30, 2016	Sep. 30, 2017	Sep. 30, 2016
Foreign currency forward contracts | Net revenue | Designated
Derivative Instruments, Gain (Loss) [Line Items]
Amount of Deferred (Loss)/Gain Recognized in Other Comprehensive Loss	$ (16,688)	$ (6,929)	$ (56,479)	$ (12,810)
Amount of Net (Loss)/Gain Reclassified from Accumulated Other Comprehensive Loss into Net Income	(4,075)	2,771	3,678	15,075
Foreign currency forward contracts | Cost of revenue | Designated
Derivative Instruments, Gain (Loss) [Line Items]
Amount of Deferred (Loss)/Gain Recognized in Other Comprehensive Loss	1,614	(6,450)	23,041	(20,319)
Amount of Net (Loss)/Gain Reclassified from Accumulated Other Comprehensive Loss into Net Income	(1,953)	(4,834)	(13,356)	(14,857)
Foreign currency forward contracts | Other, net | Not designated
Derivative Instruments, Gain (Loss) [Line Items]
Amount of Gain/(Loss) Recognized in Net Income	(3,865)	(3,827)	(10,542)	(7,912)
Commodity forward contracts | Other, net | Not designated
Derivative Instruments, Gain (Loss) [Line Items]
Amount of Gain/(Loss) Recognized in Net Income	$ 2,956	$ 1,318	$ 6,439	$ 12,049

Other, Net (Details)

Other, Net (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2017	Sep. 30, 2016	Sep. 30, 2017	Sep. 30, 2016
Other Income and Expenses [Abstract]
Currency remeasurement gain on net monetary assets	$ 3,989	$ 1,707	$ 11,010	$ 550
Loss on foreign currency forward contracts	(3,865)	(3,827)	(10,542)	(7,912)
Gain on commodity forward contracts	2,956	1,318	6,439	12,049
Other	32	76	283	205
Other, net	$ 3,112	$ (726)	$ 7,190	$ 4,892

Segment Reporting (Details)

Segment Reporting (Details) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2017USD ($)	Sep. 30, 2016USD ($)	Sep. 30, 2017USD ($)segment	Sep. 30, 2016USD ($)
Segment Reporting [Abstract]
Number of reporting segments | segment			2
Reconciliation from Segment Totals to Consolidated [Abstract]
Net revenue	$ 819,054	$ 789,798	$ 2,466,199	$ 2,413,892
Profit from operations	140,002	122,808	400,375	364,513
Amortization of intangible assets	(40,317)	(50,562)	(121,578)	(151,572)
Restructuring and special charges	(1,329)	(837)	(18,768)	(3,167)
Interest expense, net	(40,263)	(41,176)	(120,578)	(125,201)
Other, net	3,112	(726)	7,190	4,892
Income before taxes	102,851	80,906	286,987	244,204
Operating segments
Reconciliation from Segment Totals to Consolidated [Abstract]
Net revenue	819,054	789,798	2,466,199	2,413,892
Profit from operations	235,027	222,542	693,402	652,277
Operating segments | Performance Sensing
Reconciliation from Segment Totals to Consolidated [Abstract]
Net revenue	603,932	584,650	1,825,904	1,797,395
Profit from operations	162,655	155,228	483,491	453,540
Operating segments | Sensing Solutions
Reconciliation from Segment Totals to Consolidated [Abstract]
Net revenue	215,122	205,148	640,295	616,497
Profit from operations	72,372	67,314	209,911	198,737
Corporate and other
Reconciliation from Segment Totals to Consolidated [Abstract]
Profit from operations	(53,379)	(48,335)	(152,681)	(133,025)
Segment reconciling items
Reconciliation from Segment Totals to Consolidated [Abstract]
Amortization of intangible assets	(40,317)	(50,562)	(121,578)	(151,572)
Restructuring and special charges	$ (1,329)	$ (837)	$ (18,768)	$ (3,167)

Net Income per Share - Schedule

Net Income per Share - Schedule of Weighted Average Number of Shares (Details) - shares shares in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2017	Sep. 30, 2016	Sep. 30, 2017	Sep. 30, 2016
Weighted Average Number of Shares Outstanding, Diluted [Abstract]
Basic weighted-average ordinary shares outstanding (in shares)	171,269	170,840	171,116	170,656
Dilutive effect of stock options (in shares)	618	431	567	504
Dilutive effect of unvested restricted securities (in shares)	358	207	340	199
Diluted weighted-average ordinary shares outstanding (in shares)	172,245	171,478	172,023	171,359

Net Income per Share - Schedu59

Net Income per Share - Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share (Details) - shares shares in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2017	Sep. 30, 2016	Sep. 30, 2017	Sep. 30, 2016
Anti-dilutive shares excluded
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share (in shares)	1,584	1,355	1,635	1,418
Contingently issuable shares excluded
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share (in shares)	884	735	783	632